Medical Weight Loss Program
Choose the perfect Prescription weight loss solution tailored to your needs!
Semaglutide :
Mechanism of Action: GLP-1 receptor agonist only.
Weight Loss Efficacy:
Tirzepatide :
Mechanism of Action: Combines GLP-1 and GIP receptor agonists.
Weight Loss Efficacy:
WARNING: RISK OF THYROID C-CELL TUMORS
See full prescribing information for complete boxed warning.
In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether Semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined
Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk for MTC with the use of Wegovy® and inform them of symptoms of thyroid tumors (e.g. a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with Semaglutide
Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2, and in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Semaglutide. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with Semaglutide.
Disclaimer: Prescription products are only available if prescribed by a qualified healthcare provider after consultation. Individual results may vary and are not guaranteed. Semaglutide and Tirzepatide are compounded products and have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
WARNING: RISK OF THYROID C-CELL TUMORS
Tirzepatide may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
Tirzepatide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors (4, 5.1).
Do not use Tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
Do not use Tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use Tirzepatide if you have had a serious allergic reaction to Tirzepatide.
Begin your weight loss journey in 3 easy steps
Step 1
Comprehensive medical examination.
Body composition test.
Step 2
Analyze current lifestyle habits and create a plan for improvement.
Evaluate health risks and establish necessary lifestyle changes.
Establish your weight goals.
Step 3
Begin your weight loss journey under the close supervision of our clinical team.
You are not alone. we are with you every step of the way.
Our Approach:
Our medical weight loss program is ongoing and comprehensive. We provide not just medication but also health coaching to help you achieve a healthy lifestyle through proper nutrition and exercise. Our team offers personalized, continuous care with easy access to clinical support, ensuring close supervision to prevent unwanted side effects and complications.
Switch to Rybelsus®, the hassle-free oral solution for managing your health. Known generically as Semaglutide, this daily pill offers a needle-free alternative to traditional treatments.
Easy Daily Regimen: Take just one pill a day with Rybelsus® for consistent health management.
Cost-Effective Consultations: Start with an initial consultation.
Affordable Maintenance: Manage your health.
Regular Follow-Ups: Ensure optimal health with regular follow-up visits.
No Needles
Pills instead of injections.
Convenience
Easy to take at home or on the go.
Pain-Free
No pain or discomfort.
Fast and Effective
Quick action and efficiency.
Pre-Holiday Special Packages
Semaglutide:
3-Month Package: $2,500
(Regular Price $2,750)
Tirzepatide :
3-Month Package: $2,750
(Regular Price $3,000)
Nausea
Abdominal pain
Heartburn
Diarea ( or constipation)
Hydration and Diet Adjustments:
Increase your water intake and adjust your diet to help manage nausea and digestion issues. If symptoms persist, please contact our office.
How long it takes to see results
Most people start seeing weight loss of 1 to 3 pounds per week with proper lifestyle changes. Specific results from treatments like Tirzepatide and Semaglutide can vary:
Tirzepatide: Average weight loss is 20.9% by 36 weeks and 25.3% by 88 weeks, leveraging GLP-1 and GIP receptor agonists.
Semaglutide: Typically achieves an average weight loss of 15.2%, focusing on GLP-1 receptor agonists.
Visible results can usually be noticed within a few weeks to months, depending on individual adherence to the prescribed lifestyle modifications.
Additional Services:
Request a Consultation
Real Results!
Frequently Asked Questions
On average, people lose between 1 to 3 pounds per week with proper lifestyle modifications. Individual results may vary based on nutrition, exercise, and overall health.
Muscle loss can occur as a natural metabolic process, but with proper nutrition and exercise, significant muscle loss can be controlled and prevented.
Weight loss is an ongoing process that requires continuous lifestyle changes. The length of treatment will vary depending on factors like your metabolic health, lifestyle modifications, and daily habits.
The program can last between 6 months to 1 year, but it can be adjusted or stopped at any time with a proper titration treatment plan.
Common side effects include nausea, abdominal pain, heartburn, diarrhea, or constipation. These can often be controlled with proper dosing and nutrition.
If you notice any side effects, report them to our office immediately so we can adjust your treatment plan.
Some studies suggest that alcohol may not be well-tolerated with GLP-1 treatments. It’s important to discuss alcohol consumption with your healthcare provider.
Yes, the program can be adjusted or discontinued based on your progress and goals, with guidance from your healthcare provider to ensure a proper transition.
